Ashley Bush

Professor Ashley Bush (MB BS, DPM, FRANZCP, PhD, FTSE) is a psychiatrist and translational neuroscientist, who is the Chief Scientific Officer of the CRC for Mental Health, heads the Oxidation Biology Laboratory at the Mental Heath Research Institute, The University of Melbourne, is co-director of Biomarker Discovery within the Australian Imaging Biomarker Lifestyle Flagship Study of Ageing (AIBL), a lecturer in psychiatry at Massachusetts General Hospital, Harvard Medical School (MGH) and adjunct professor of neuroscience at Cornell University.

Professor Bush has authored over 230 publications, with over 16,000 citations, 21 patents and has founded 3 biotechnology companies. After training in medicine and psychiatry, he received his PhD in Colin Masters’ lab at the University of Melbourne in 1993, performed post-doctoral studies with Rudy Tanzi at MGH, directed a lab at MGH from 1995-2005, whereupon he was appointed as ARC Federation Fellow and Professor of Pathology at his current location. He discovered the interaction of beta-amyloid with zinc as a major factor in Alzheimer’s disease pathogenesis, and focuses on the neurobiology of metal ions in neurodegenerative disorders.